<DOC>
	<DOCNO>NCT00278980</DOCNO>
	<brief_summary>The aim study investigate effect C-peptide administration nerve function patient type 1 diabetes peripheral sensory neuropathy .</brief_summary>
	<brief_title>Effect C-Peptide Diabetic Peripheral Neuropathy</brief_title>
	<detailed_description>It observe C-peptide administration result activation renal tubular sciatic endoneural Na/K-ATPase rat stimulation endothelial nitric oxide synthase . The hypothesis C-peptide administration may improve peripheral nerve dysfunction diabetic neuropathy increase nerve blood flow Na/K-ATPase activity . The purpose trial investigate effect C-peptide administration diabetic peripheral sensory neuropathy patient type 1 diabetes diabetic neuropathy low extremity .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Peripheral Nervous System Diseases</mesh_term>
	<mesh_term>Polyneuropathies</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Diabetic Neuropathies</mesh_term>
	<criteria>Subjects duration type 1 diabetes 5 yr Subjects Cpeptide deficient Subjects diabetic distal symmetric neuropathy , accord criterion define San Antonio Conference Diabetic Neuropathy 1988 Subjects measurable action potential sural nerve Subjects reduce nerve conduction velocity sural nerve Subjects neuropathy sign nerve dysfunction may consequence factor type 1 diabetes Subjects concomitant medication may interfere peripheral nerve function measurement thereof Subjects transplant ( islet cell , kidney pancreas )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>January 2006</verification_date>
</DOC>